Is Mojo (testosterone) weekly injections indicated for a 27-year-old patient with obstructive sleep apnea (OSA), a body mass index (BMI) of 55, and a history of cardiovascular disease and chronic lung disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone Injections Are Contraindicated in This Patient

Testosterone replacement therapy should NOT be initiated in this 27-year-old patient with severe obesity (BMI 55), untreated obstructive sleep apnea, and cardiovascular/pulmonary comorbidities, as testosterone can worsen OSA severity and increase cardiovascular risk in patients with severe untreated sleep apnea. 1, 2, 3

Primary Contraindications

Severe Untreated OSA

  • Testosterone replacement therapy is generally contraindicated by guidelines in the presence of untreated or severe OSAS, as TRT can worsen OSA symptoms through multiple mechanisms 3
  • With a BMI of 55, this patient has an extremely high likelihood (70-90%) of having severe OSA, which significantly increases perioperative and cardiovascular mortality risk 4
  • TRT should probably be avoided in patients with severe untreated OSA due to potential exacerbation of respiratory dysfunction 1
  • Testosterone supplementation alters ventilatory responses, possibly through effects on central chemoreceptors, which can worsen apneic episodes 2

Cardiovascular Disease History

  • The combination of severe obesity, OSA, and pre-existing heart disease creates a high-risk profile for cardiovascular mortality 5
  • OSA is strongly associated with hypertension, myocardial infarction, heart failure, and stroke, and these risks are amplified in the presence of cardiovascular disease 5
  • TRT might exacerbate polycythaemia, which is already a risk factor in OSAS patients, further increasing cardiovascular complications 3

Required Management Sequence

Step 1: Diagnose and Treat OSA First

  • Polysomnography is required to confirm OSA diagnosis and severity before considering any testosterone therapy 4
  • With BMI 55, history of snoring, and cardiopulmonary disease, this patient requires immediate sleep study evaluation 5
  • Weight reduction is recommended to reduce this important risk factor for OSA, with evidence showing improvement in breathing pattern, quality of sleep, and daytime sleepiness 5

Step 2: Initiate CPAP Therapy

  • CPAP treatment should be the cornerstone of initial management, as it can improve testosterone levels without hormonal supplementation 6
  • In most cases, CPAP therapy can revert low serum testosterone levels to normal levels without the need for TRT 6
  • CPAP may lower pulmonary artery pressures when the degree of pulmonary hypertension is mild, addressing the cardiovascular concerns 5

Step 3: Address Obesity

  • Weight loss has been accompanied by improvement in characteristics related not only to obesity but to OSA as well, suggesting that weight loss should be a cornerstone of treatment 7
  • With BMI 55, bariatric surgery should be considered, as it has shown impressive results with respect to sleep apnea severity and cardiometabolic disturbances 7
  • Weight reduction is associated with a trend to improvement in breathing pattern and is recommended as a critical intervention 5

When TRT Might Be Reconsidered

Only After OSA Treatment

  • With OSA treatment, TRT may not only improve hypogonadism, but may also alleviate erectile/sexual dysfunction - but only after adequate OSA management 2
  • Patients should be asked about OSA symptoms before and after starting TRT, with ongoing monitoring 1
  • Long-term lower doses of testosterone could eventually determine clinical improvement of OSAS symptoms, but this requires careful individualization after OSA is controlled 3

Critical Pitfalls to Avoid

  • Never initiate TRT without first documenting testosterone deficiency through laboratory testing - the question assumes testosterone deficiency but this must be confirmed 1
  • Do not assume that symptoms of fatigue or sexual dysfunction are solely due to low testosterone - these are also primary symptoms of untreated OSA 6
  • Avoid short-term high-dose TRT even after OSA treatment, as this might worsen OSAS more than long-term lower doses 3
  • Do not overlook that depressive status and fatigue as OSAS consequences may have notable improvement after CPAP therapy, avoiding the need for hormonal treatment 6

References

Research

Obstructive Sleep Apnea and Testosterone Deficiency.

The world journal of men's health, 2019

Research

Testosterone Deficiency and Sleep Apnea.

Sleep medicine clinics, 2016

Guideline

Obstructive Sleep Apnea Risk Assessment in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.